JW Pharmaceutical Corp. | |
Stock Exchange | Korea Exchange Commodity Market |
EPS |
KRW66.42 |
Market Cap |
KRW632.13 B |
Shares Outstanding |
20.32 M |
Public Float |
11.28 M |
JW Pharmaceutical Corp. Pfd. Series 2 | |
Stock Exchange | Korea Exchange Commodity Market |
EPS |
- |
Market Cap |
KRW1.05 T |
Shares Outstanding |
86.1 K |
Public Float |
- |
JW Pharmaceutical Corp. Pfd. Series 1 | |
Stock Exchange | Korea Exchange Commodity Market |
EPS |
KRW66.42 |
Market Cap |
KRW524.77 B |
Shares Outstanding |
167.38 K |
Public Float |
160 K |
Address |
JW Tower Seoul SL 06725 Korea, Republic Of |
Employees | - |
Website | http://www.jw-pharma.co.kr |
Updated | 07/08/2019 |
JW PHARMACEUTICAL Corp. engages in the development, manufacture, and sale of pharmaceuticals. Its products include analgesics, antipyretics and cold remedy, antidote agents, antimicrobials, anticancer agents, antifungal agents, circulatory system agents, gastrointestinal agents, miscellaneous, multivitamins and anti-anemic agents, contact lens care and ophthalmic agents, topicals, amino acid solutions, flexible intravenous container, intravenous solutions, respiratory agents, obstetrics and gynecology agents, nephrology agents, central nervous system, urology agents, and diabetic agents. The company was founded on August 8, 1945 and is headquartered in Seoul, South Korea. |